314 related articles for article (PubMed ID: 19075706)
21. Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease.
Quinn J; Montine T; Morrow J; Woodward WR; Kulhanek D; Eckenstein F
J Neuroimmunol; 2003 Apr; 137(1-2):32-41. PubMed ID: 12667645
[TBL] [Abstract][Full Text] [Related]
22. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
Coria F; Castaño EM; Frangione B
Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
[TBL] [Abstract][Full Text] [Related]
23. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
25. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.
Yamada M; Ono K; Hamaguchi T; Noguchi-Shinohara M
Adv Exp Med Biol; 2015; 863():79-94. PubMed ID: 26092627
[TBL] [Abstract][Full Text] [Related]
26. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
[TBL] [Abstract][Full Text] [Related]
27. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
28. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
29. Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond.
Leuchtenberger S; Beher D; Weggen S
Curr Pharm Des; 2006; 12(33):4337-55. PubMed ID: 17105431
[TBL] [Abstract][Full Text] [Related]
30. Protein aggregation diseases: pathogenicity and therapeutic perspectives.
Aguzzi A; O'Connor T
Nat Rev Drug Discov; 2010 Mar; 9(3):237-48. PubMed ID: 20190788
[TBL] [Abstract][Full Text] [Related]
31. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
Ozben T; Ozben S
Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
[TBL] [Abstract][Full Text] [Related]
32. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
33. Amyloidosis: new strategies for treatment.
Hirschfield GM; Hawkins PN
Int J Biochem Cell Biol; 2003 Dec; 35(12):1608-13. PubMed ID: 12962700
[TBL] [Abstract][Full Text] [Related]
34. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
McGeer PL; McGeer EG
Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
[TBL] [Abstract][Full Text] [Related]
35. Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.
Thomas T; Nadackal TG; Thomas K
Neuroreport; 2001 Oct; 12(15):3263-7. PubMed ID: 11711868
[TBL] [Abstract][Full Text] [Related]
36. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?
Weggen S; Rogers M; Eriksen J
Trends Pharmacol Sci; 2007 Oct; 28(10):536-43. PubMed ID: 17900710
[TBL] [Abstract][Full Text] [Related]
37. Disease-modifying therapies in Alzheimer's disease: how far have we come?
Hüll M; Berger M; Heneka M
Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
[TBL] [Abstract][Full Text] [Related]
38. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
[TBL] [Abstract][Full Text] [Related]
39. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
40. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
